Scinovex
review Open AccessTop 1% cited

Guidelines for the management of adult lower respiratory tract infections

European Respiratory Journal · 2005 · Vol. 26(6) · pp. 1138–1180
Mark WoodheadF. BlasiS. EwigG. HuchonM. LevenA. OrtqvistT. SchabergA. TorresG. van der HeijdenT. J. M. Verheij

Abstract

No risk factors for P. aeruginosa (see table 12) Nonantipseudomonal cephalosporin III+macrolide # or Nonantipseudomonal cephalosporin III+(moxifloxacin or levofloxacin) Risk factors for P. aeruginosa (see table 12) Anti-pseudomonal cephalosporin " or Acylureidopenicillin/b-lactamase inhibitor or Carbapenem + ciprofloxacin P. aeruginosa: Pseudomonas aeruginosa.# : new macrolides preferred to erythromycin

Respiratory and Cough-Related ResearchChronic Obstructive Pulmonary Disease (COPD) ResearchPediatric health and respiratory diseasesGuidelineMedicineIntensive care medicineRespiratory tract infectionsPneumoniaCommunity-acquired pneumoniaTask forceSpecialtyPublic healthFamily medicine

MeSH terms

AdultAmbulatory CareAnti-Bacterial AgentsDrug Therapy, CombinationFemaleHospitalizationHumansMaleMiddle AgedPneumoniaPrognosisRespiratory Tract InfectionsSeverity of Illness IndexSurvival RateTreatment Outcome
Citations
891
FWCI
40.11
field-weighted impact
References
389
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Guidelines for the management of adult lower respiratory tract infections · Scinovex